Skip to main content

Biomarin Pharmaceutical Inc 10-Q for FY2025 Q3

Biomarin Pharmaceutical Inc (BMRN)

10-Q 2025-10-28 For: 2025-09-30
View Original
Added on April 12, 2026

About this 10-Q

Biomarin Pharmaceutical Inc filed this 10-Q on October 28, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$776.13M
up 4.1% from $745.74M a year earlier
Net loss
$30.74M
compared with net income of $106.08M a year earlier
Diluted EPS
-$0.16
compared with $0.55 a year earlier